SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas will participate on a panel at BioFlorida's 10th annual conference titled "Raising Capital" on October 17 in Weston, FL.
News | 10. 17. 2007
